Charles University
Prague, 150 06, Czechia
NCT Number: NCT03638310
The aim of this study is to assess effect of psychiatric profile on visual sensitivity and overall health status in patients who underwent surgery for vestibular schwannoma and were prehabituated by chemical vestibular ablation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Prague, 150 06, Czechia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
under local anesthesia is gentamicin instilled through tympanic membrane to tympanic cavity
surgery under general anesthesia
Time frame: change of the gain of optokinetic nystagmus among 3 time points is measured: before intervention, 1 week after intervention, 3 months after intervention
During electronystagmography gain of optokinetic nystagmus is measured before and after the intervention
Charles University, Czech Republic
Other
Assessment of Visual Sensitivity, Psychiatric Profile and Quality of Life Following Vestibular Schwannoma Surgery in Patients Prehabituated by Chemical Vestibular Ablation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07267910
Cranial Nerve Diseases, Cranial Nerve Neoplasms
Helsinki, Finland
View Trial DetailsNCT05622344
Cranial Nerve Diseases, Cranial Nerve Neoplasms
Baltimore, Maryland, United States
View Trial DetailsNCT05786144
Cranial Nerve Diseases, Cranial Nerve Neoplasms
Maastricht, Limburg, Netherlands
View Trial DetailsNCT04057976
Cranial Nerve Diseases, Cranial Nerve Neoplasms
London, United Kingdom
View Trial Details